NFKB1 and colorectal carcinoma: The mechanism of the anti-CRC effect of FxOH was evaluated via regulation of MAPK and STAT apoptosis pathways in HT-29 and HCT-116 cell lines (107), and through inhibiting NF-κB activation in CRC cells (108).